NO984229L - Forbindelser og fremgangsmÕter for immunoterapi og immunodiagnose av prostatakreft - Google Patents
Forbindelser og fremgangsmÕter for immunoterapi og immunodiagnose av prostatakreftInfo
- Publication number
- NO984229L NO984229L NO984229A NO984229A NO984229L NO 984229 L NO984229 L NO 984229L NO 984229 A NO984229 A NO 984229A NO 984229 A NO984229 A NO 984229A NO 984229 L NO984229 L NO 984229L
- Authority
- NO
- Norway
- Prior art keywords
- prostate cancer
- polypeptides
- compounds
- methods
- immunotherapy
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title abstract 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000009169 immunotherapy Methods 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 238000002619 cancer immunotherapy Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61674596A | 1996-03-15 | 1996-03-15 | |
US63384096A | 1996-04-11 | 1996-04-11 | |
PCT/US1997/004192 WO1997033909A2 (en) | 1996-03-15 | 1997-03-14 | Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984229D0 NO984229D0 (no) | 1998-09-14 |
NO984229L true NO984229L (no) | 1998-11-13 |
Family
ID=27087847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984229A NO984229L (no) | 1996-03-15 | 1998-09-14 | Forbindelser og fremgangsmÕter for immunoterapi og immunodiagnose av prostatakreft |
Country Status (11)
Country | Link |
---|---|
US (1) | US6034218A (ko) |
EP (1) | EP0914335A2 (ko) |
KR (1) | KR19990087802A (ko) |
AR (1) | AR006250A1 (ko) |
AU (1) | AU728186B2 (ko) |
BR (1) | BR9708082A (ko) |
CA (1) | CA2249742A1 (ko) |
CO (1) | CO4600637A1 (ko) |
NO (1) | NO984229L (ko) |
NZ (1) | NZ331866A (ko) |
WO (1) | WO1997033909A2 (ko) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6592877B1 (en) * | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6458366B1 (en) | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
US6290969B1 (en) * | 1995-09-01 | 2001-09-18 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
SE520392C2 (sv) | 1996-09-27 | 2003-07-01 | Creative Peptides Sweden Ab C | Specifika peptider för behandling av diabetes mellitus |
US7033827B2 (en) | 1997-02-25 | 2006-04-25 | Corixa Corporation | Prostate-specific polynucleotide compositions |
US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6395278B1 (en) | 1997-02-25 | 2002-05-28 | Corixa Corporation | Prostate specific fusion protein compositions |
US6800746B2 (en) | 1997-02-25 | 2004-10-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US20030185830A1 (en) | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6261562B1 (en) | 1997-02-25 | 2001-07-17 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
US6620922B1 (en) | 1997-02-25 | 2003-09-16 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6613872B1 (en) | 1997-02-25 | 2003-09-02 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
CN1195851C (zh) | 1997-02-25 | 2005-04-06 | 科里克萨有限公司 | 用于前列腺癌免疫疗法的化合物及其用途 |
US6329505B1 (en) | 1997-02-25 | 2001-12-11 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
US6465611B1 (en) | 1997-02-25 | 2002-10-15 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
US6630305B1 (en) | 1999-11-12 | 2003-10-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6759515B1 (en) | 1997-02-25 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6818751B1 (en) | 1997-08-01 | 2004-11-16 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6943236B2 (en) | 1997-02-25 | 2005-09-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6894146B1 (en) | 1997-02-25 | 2005-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7202342B1 (en) | 1999-11-12 | 2007-04-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6555653B2 (en) * | 1997-05-20 | 2003-04-29 | Corixa Corporation | Compounds for diagnosis of tuberculosis and methods for their use |
US7087713B2 (en) * | 2000-02-25 | 2006-08-08 | Corixa Corporation | Compounds and methods for diagnosis and immunotherapy of tuberculosis |
WO1999018210A2 (en) * | 1997-10-07 | 1999-04-15 | Corixa Corporation | Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
WO1999037778A2 (en) * | 1998-01-26 | 1999-07-29 | Genquest, Inc. | Compositions and methods for detecting and treating prostate cancer |
TR200100916T2 (ko) * | 1998-07-14 | 2002-06-21 | Corixa@@Corporation | |
US6458925B1 (en) | 1998-08-03 | 2002-10-01 | University Of Maryland, Baltimore | Peptide antagonists of zonulin and methods for use of the same |
US6387888B1 (en) | 1998-09-30 | 2002-05-14 | American Foundation For Biological Research, Inc. | Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen |
GB9828840D0 (en) * | 1998-12-30 | 1999-02-17 | Univ Nottingham Trent | Prostate cancer associated genes and their products |
US8143386B2 (en) * | 1999-04-07 | 2012-03-27 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
WO2000073469A2 (en) * | 1999-05-28 | 2000-12-07 | Sugen, Inc. | Protein kinases |
CA2340721A1 (en) * | 1999-06-21 | 2001-01-25 | George Tuszynski | Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
US20020058292A1 (en) * | 2000-12-08 | 2002-05-16 | Dillon Davin C. | Ovarian tumor antigen and methods of use therefor |
WO2001024820A1 (en) * | 1999-10-07 | 2001-04-12 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
WO2001034802A2 (en) * | 1999-11-12 | 2001-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
CA2397741A1 (en) * | 2000-01-14 | 2001-07-19 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
AU2001259228A1 (en) * | 2000-04-26 | 2001-11-07 | The Scripps Research Institute | Pancreatic progenitor 1 gene and its uses |
WO2001098460A2 (en) * | 2000-06-20 | 2001-12-27 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
WO2002006330A2 (en) * | 2000-07-18 | 2002-01-24 | Millennium Pharmaceuticals, Inc. | 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor |
AU2001279082A1 (en) * | 2000-07-31 | 2002-02-13 | Gene Logic, Inc. | Expression of gage/page-like protein in benign prostatic hyperplasia |
US7048931B1 (en) | 2000-11-09 | 2006-05-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
MXPA03004637A (es) | 2000-11-28 | 2003-09-05 | Wyeth Corp | Analisis de expresion de acidos nucleicos y polipeptidos kiaa utiles en diagnostico y tratamiento de cancer de prostata. |
IL155952A0 (en) | 2000-11-28 | 2003-12-23 | Wyeth Corp | Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
JP2004527225A (ja) * | 2000-11-28 | 2004-09-09 | ワイス | 前立腺癌の診断および治療に有用なsmarc核酸およびポリペプチドの発現分析 |
CA2439442A1 (en) * | 2001-02-26 | 2002-09-06 | Xianghe Yan | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
EP2295074A1 (en) * | 2001-03-07 | 2011-03-16 | Mannkind Corporation | Anti-neovasculature preparations for treating cancer |
US20030118585A1 (en) * | 2001-10-17 | 2003-06-26 | Agy Therapeutics | Use of protein biomolecular targets in the treatment and visualization of brain tumors |
US20050085627A1 (en) | 2001-06-21 | 2005-04-21 | Youming Zhang | Atopy |
WO2003008582A1 (en) * | 2001-07-19 | 2003-01-30 | The New Industry Research Organization | Novel human-origin protein binding to sphingosine kinase 1 and polynucleotide encoding the protein |
US8507445B2 (en) * | 2001-09-07 | 2013-08-13 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
WO2003070187A2 (en) * | 2002-02-15 | 2003-08-28 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
DE10217254A1 (de) * | 2002-04-15 | 2003-10-23 | Proteosys Ag | Verwendung von Substanzen zur Behandlung von Tumoren |
US8435507B2 (en) * | 2004-08-19 | 2013-05-07 | University Of Maryland | Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer |
EP2612870A1 (en) | 2005-09-12 | 2013-07-10 | The Regents of the University of Michigan | Recurrent gene fusions in prostate cancer |
US9957569B2 (en) * | 2005-09-12 | 2018-05-01 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
DK2777695T3 (en) | 2006-02-09 | 2018-12-17 | Alba Therapeutics Corp | Formulations for a tight-junction effector |
EP2057465A4 (en) * | 2006-08-09 | 2010-04-21 | Homestead Clinical Corp | SPECIFIC ORGAN PROTEINS AND METHODS OF USE |
US20090069247A1 (en) | 2006-10-06 | 2009-03-12 | Blake Paterson | Use of tight junction antagonists to treat inflammatory bowel disease |
US8034776B2 (en) | 2006-10-26 | 2011-10-11 | Alba Therapeutics Corporation | Materials and methods for the treatment of celiac disease |
AU2007317306B2 (en) * | 2006-11-08 | 2012-06-14 | The Regents Of The University Of Michigan | SPINK1 as a prostate cancer marker and uses thereof |
US9962424B2 (en) * | 2007-04-27 | 2018-05-08 | Lantmännen As-Faktor Ab | Use of antisecretory factors (AF) for optimizing cellular uptake |
CA2814246A1 (en) | 2007-07-06 | 2009-01-15 | The Regents Of The University Of Michigan | Solute carrier family 45 member 3 (slc45a3) and erg family gene fusions in prostate cancer |
WO2009009431A2 (en) | 2007-07-06 | 2009-01-15 | The Regents Of The University Of Michigan | Mipol1-etv1 gene rearrangements |
EP2179292B1 (en) | 2007-08-16 | 2012-11-28 | The Regents of the University of Michigan | Metabolomic profiling of prostate cancer |
AU2009253675A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
JP2012514475A (ja) | 2009-01-09 | 2012-06-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 癌における再現性の遺伝子融合物 |
US20100311815A1 (en) * | 2009-02-23 | 2010-12-09 | The Regents Of The University Of Michigan | Mir-101 cancer markers |
US9938582B2 (en) * | 2009-09-17 | 2018-04-10 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
US8945556B2 (en) | 2010-11-19 | 2015-02-03 | The Regents Of The University Of Michigan | RAF gene fusions |
EP3336200A1 (en) | 2010-11-19 | 2018-06-20 | The Regents Of The University Of Michigan | Prostate cancer ncrna and uses thereof |
EP2885640B1 (en) | 2012-08-16 | 2018-07-18 | Genomedx Biosciences, Inc. | Prostate cancer prognostics using biomarkers |
US11686731B2 (en) | 2015-01-05 | 2023-06-27 | Ian Mills | Prostate cancer markers and uses thereof |
US11414708B2 (en) | 2016-08-24 | 2022-08-16 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
CA3050984A1 (en) | 2017-01-20 | 2018-07-26 | Decipher Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
US11873532B2 (en) | 2017-03-09 | 2024-01-16 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
AU2018266733A1 (en) | 2017-05-12 | 2020-01-16 | Veracyte, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990009446A1 (en) * | 1989-02-17 | 1990-08-23 | Plant Genetic Systems N.V. | Cutinase |
EP1757694A3 (en) * | 1992-11-05 | 2008-02-27 | Sloan Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
ATE303160T1 (de) * | 1993-08-11 | 2005-09-15 | Jenner Technologies | Impfstoff gegen prostatakrebs |
-
1997
- 1997-03-14 AU AU23295/97A patent/AU728186B2/en not_active Ceased
- 1997-03-14 CO CO97013952A patent/CO4600637A1/es unknown
- 1997-03-14 BR BR9708082A patent/BR9708082A/pt unknown
- 1997-03-14 CA CA002249742A patent/CA2249742A1/en not_active Abandoned
- 1997-03-14 AR ARP970101046A patent/AR006250A1/es unknown
- 1997-03-14 WO PCT/US1997/004192 patent/WO1997033909A2/en not_active Application Discontinuation
- 1997-03-14 KR KR1019980707293A patent/KR19990087802A/ko not_active Application Discontinuation
- 1997-03-14 NZ NZ331866A patent/NZ331866A/xx unknown
- 1997-03-14 EP EP97916017A patent/EP0914335A2/en not_active Withdrawn
- 1997-10-07 US US08/946,026 patent/US6034218A/en not_active Expired - Fee Related
-
1998
- 1998-09-14 NO NO984229A patent/NO984229L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU728186B2 (en) | 2001-01-04 |
BR9708082A (pt) | 1999-07-27 |
AU2329597A (en) | 1997-10-01 |
KR19990087802A (ko) | 1999-12-27 |
US6034218A (en) | 2000-03-07 |
WO1997033909A3 (en) | 1997-12-24 |
EP0914335A2 (en) | 1999-05-12 |
WO1997033909A2 (en) | 1997-09-18 |
CA2249742A1 (en) | 1997-09-18 |
AR006250A1 (es) | 1999-08-11 |
NO984229D0 (no) | 1998-09-14 |
CO4600637A1 (es) | 1998-05-08 |
NZ331866A (en) | 2000-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO984229L (no) | Forbindelser og fremgangsmÕter for immunoterapi og immunodiagnose av prostatakreft | |
WO1998037418A3 (en) | Compounds for immunodiagnosis of prostate cancer and methods for their use | |
EA200101037A1 (ru) | Соединения и способы для лечения и диагностики рака легкого | |
WO2004037999A3 (en) | A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same | |
WO2000073801A3 (en) | Breast, gastric and prostate cancer associated antigens and uses therefor | |
ATE353974T1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
NO20004631L (no) | Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft | |
AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
HUP0103758A2 (hu) | Neurotróf faktorok | |
WO2000037643A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
MX9801687A (es) | Compuestos y metodos para el diagnostico de tuberculosis. | |
ES2133813T3 (es) | Cadenas de lamininas: diagnostico y uso terapeutico. | |
WO1997008314A3 (en) | Telomere repeat binding factor and diagnostic and therapeutic use thereof | |
ATE301716T1 (de) | Vmp-ähnliche sequenzen von pathogener borrelia | |
WO2001049716A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
DK11187A (da) | Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem | |
BR0016432A (pt) | Molécula de ácido nucleico isolada, vetor, célula hospedeira, descendentes, sementes ou material celular reproduzìvel, método de produção de um ou mais polipeptìdeo(s), tcmrp isolada, polipeptìdeo isolado, anticorpo, kit de teste, método para produzir um produto quìmico fino, produto quìmico fino, e, uso de um produto quìmico fino ou de polipeptìdeo(s). | |
WO1999018210A3 (en) | Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer | |
AP2000001917A0 (en) | Gene encoding labyrinthin, a marker for cancer. | |
AU1959001A (en) | Histone deacetylase-8 proteins, nucleic acids, and methods of use | |
NO20022711L (no) | Fremgangsmåte for testing av et terapeutisk eller profylaktisk middel for hyperlipidemi | |
WO2001002561A3 (en) | Mammalian calcium channels and related probes, cell lines and methods | |
WO2001051513A3 (en) | Ovarian tumor-associated sequences | |
DK0629238T3 (da) | Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |